| Financial Year |
March 31 2023 |
| Monetary Funds |
2,424,717,165.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
214,907,825.61 |
| Accounts Receivable |
4,333,243,842.24 |
| Advances to Suppliers |
255,915,529.45 |
| Other Receivables |
160,214,340.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,738,316,960.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,166,282.55 |
| Total Current Assets |
9,711,841,748.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
47,160,987.52 |
| Fixed Assetes |
2,424,484,330.22 |
| Under-construction Projects |
79,600,969.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
435,622,122.31 |
| R&D expenses |
53,129,063.42 |
| Goodwill |
39,146,642.53 |
| Long-Term Deferred and Prepaid Expenses |
16,179,215.02 |
| Deferred Income Tax Assets |
601,442,736.42 |
| Other Non-Current Assets |
974,000.00 |
| Sub-Total of Non-Current Assets |
3,829,114,933.55 |
| Total Assets |
13,540,956,681.83 |
| Short-Term Loans |
1,861,254,403.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,287,802,978.64 |
| Accounts Payable |
2,404,360,231.04 |
| Accounts Received In Advance |
7,068,879.03 |
| Employee Compensation Payable |
479,111,567.38 |
| Taxes Payable |
150,271,588.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,324,604,708.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
130,028,141.31 |
| Other Current Liabilities |
168,746,861.53 |
| Sub-Total of Current Liabilities |
7,958,525,681.18 |
| Long-term Loans |
33,409,209.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,989,354.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
489,422,220.77 |
| Total Liabilities |
8,447,947,901.95 |
| Paid-In Capital(Or Share Stock) |
2,523,809,076.00 |
| Capital Surplus |
688,104,457.10 |
| Surplus Reserve |
1,285,223,044.53 |
| LESS:Treasury Stock |
9,643,612.00 |
| Undistributed Profits |
1,726,966,511.52 |
| Minority Stockholder's Interest |
637,675,359.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,455,333,420.22 |
| Owner's Equity（Stockholder's Equity） |
5,093,008,779.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,540,956,681.83 |
